Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea · Delayed Price · Currency is KRW 15,100
+230 (1.55%)
At close: Oct 16, 2026
Cell Biotech Market Cap
Cell Biotech has a market cap or net worth of 103.34 billion as of October 16, 2026. It is the 27,242nd most valuable company in the world and the 1,257th biggest in South Korea. Its market cap has increased by 22.27% in one year.
Market Cap
103.34B
Enterprise Value
7.12B
Revenue
60.40B
Global Rank
Country Rank
#1,257 South Korea
PE Ratio
6.15
ChartMarket Cap Chart
Since March 3, 2003, Cell Biotech's market cap has increased from 13.97B to 103.34B, an increase of 639.85%. That is a compound annual growth rate of 8.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 103.34B | 15.18% |
| Dec 30, 2025 | 89.72B | -8.13% |
| Dec 30, 2024 | 97.66B | 27.18% |
| Dec 28, 2023 | 76.79B | -11.65% |
| Dec 29, 2022 | 86.92B | -34.80% |
| Dec 30, 2021 | 133.30B | -19.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 133.27B |
| TiumBio | 124.81B |
| ViGenCell | 111.11B |
| Y-Biologics | 107.57B |
| AriBioLab | 103.37B |
| Prestige Biologics | 99.83B |
| CORESTEMCHEMON | 88.23B |
| BIO-FD&C | 84.09B |